We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Spanish pharmaceuticals group Zeltia has denied claims in the local
media that its biotechnology business PharmaMar is the subject of an attractive
acquisition bid from an unidentified US or European firm.
Royal DSM NV, the leading Netherlands-based vitamins producer, has
claimed that Chinese competition has led to a deterioration in results for its
anti-infective pharmaceuticals business.
A study conducted by Rand Merchant Bank on South Africa's private healthcare
groups, which was leaked to local media sources, has indicated that anti-competitive
practices exist in the sector.
According to local studies, Swiss drug majors Novartis and Roche account for
33.7 percent of Brazil's oncology treatments market, which was worth a total
BRL1.2bn (US$463.76mn) in the first nine months of 2004.
Italian health authorities are to introduce a drug-tracking system designed
to trace individual packets at all stages of the distribution chain, from production
to the final consumer.
European Union officials have awarded a EUR10.7mn (US$13.95mn) five-year
grant to a new discovery project, known as EICOSANOX, to be managed under the
auspices of Sweden's Karolinska Institutet.